Mucosal Vaccines from Plant Biotechnology

Hugh Mason, Eva Thuenemann, Hiroshi Kiyono, Sarah Kessans, Nobuyuki Matoba, Tsafrir Leket-Mor

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The use of plants for production of recombinant proteins has evolved over the past 25. years. The first plant-based vaccines were expressed in stably transgenic plants, with the idea to conveniently deliver "edible vaccines" by ingestion of the antigen-containing plant material. These systems provided a proof of concept that oral delivery of vaccines in crude plant material could stimulate antigen-specific serum and mucosal antibodies. Transgenic grains like rice in particular provide a stable and robust vehicle for antigen delivery. However, some issues exist with stably transgenic plants, including relatively low expression levels and regulatory issues. Thus, many recent studies use transient expression with plant viral vectors to achieve rapid high expression in Nicotiana benthamiana, followed by purification of antigen and intranasal delivery for effective stimulation of mucosal immune responses.

Original languageEnglish (US)
Title of host publicationMucosal Immunology: Fourth Edition
PublisherElsevier Inc.
Pages1271-1289
Number of pages19
Volume2-2
ISBN (Print)9780124159754, 9780124158474
DOIs
StatePublished - Apr 1 2015

Fingerprint

Biotechnology
Vaccines
Genetically Modified Plants
Antigens
Plant Antigens
Edible Vaccines
Mucosal Immunity
Recombinant Proteins
Tobacco
Eating
Antibodies
Serum

Keywords

  • Animal vaccine
  • Cholera toxin
  • Hepatitis B
  • HIV
  • MucoRice
  • Nicotiana benthamiana
  • Norovirus
  • Plant vaccine

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Mason, H., Thuenemann, E., Kiyono, H., Kessans, S., Matoba, N., & Leket-Mor, T. (2015). Mucosal Vaccines from Plant Biotechnology. In Mucosal Immunology: Fourth Edition (Vol. 2-2, pp. 1271-1289). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-415847-4.00065-3

Mucosal Vaccines from Plant Biotechnology. / Mason, Hugh; Thuenemann, Eva; Kiyono, Hiroshi; Kessans, Sarah; Matoba, Nobuyuki; Leket-Mor, Tsafrir.

Mucosal Immunology: Fourth Edition. Vol. 2-2 Elsevier Inc., 2015. p. 1271-1289.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mason, H, Thuenemann, E, Kiyono, H, Kessans, S, Matoba, N & Leket-Mor, T 2015, Mucosal Vaccines from Plant Biotechnology. in Mucosal Immunology: Fourth Edition. vol. 2-2, Elsevier Inc., pp. 1271-1289. https://doi.org/10.1016/B978-0-12-415847-4.00065-3
Mason H, Thuenemann E, Kiyono H, Kessans S, Matoba N, Leket-Mor T. Mucosal Vaccines from Plant Biotechnology. In Mucosal Immunology: Fourth Edition. Vol. 2-2. Elsevier Inc. 2015. p. 1271-1289 https://doi.org/10.1016/B978-0-12-415847-4.00065-3
Mason, Hugh ; Thuenemann, Eva ; Kiyono, Hiroshi ; Kessans, Sarah ; Matoba, Nobuyuki ; Leket-Mor, Tsafrir. / Mucosal Vaccines from Plant Biotechnology. Mucosal Immunology: Fourth Edition. Vol. 2-2 Elsevier Inc., 2015. pp. 1271-1289
@inbook{c11928ee281f4d5a8475907d859fc07e,
title = "Mucosal Vaccines from Plant Biotechnology",
abstract = "The use of plants for production of recombinant proteins has evolved over the past 25. years. The first plant-based vaccines were expressed in stably transgenic plants, with the idea to conveniently deliver {"}edible vaccines{"} by ingestion of the antigen-containing plant material. These systems provided a proof of concept that oral delivery of vaccines in crude plant material could stimulate antigen-specific serum and mucosal antibodies. Transgenic grains like rice in particular provide a stable and robust vehicle for antigen delivery. However, some issues exist with stably transgenic plants, including relatively low expression levels and regulatory issues. Thus, many recent studies use transient expression with plant viral vectors to achieve rapid high expression in Nicotiana benthamiana, followed by purification of antigen and intranasal delivery for effective stimulation of mucosal immune responses.",
keywords = "Animal vaccine, Cholera toxin, Hepatitis B, HIV, MucoRice, Nicotiana benthamiana, Norovirus, Plant vaccine",
author = "Hugh Mason and Eva Thuenemann and Hiroshi Kiyono and Sarah Kessans and Nobuyuki Matoba and Tsafrir Leket-Mor",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/B978-0-12-415847-4.00065-3",
language = "English (US)",
isbn = "9780124159754",
volume = "2-2",
pages = "1271--1289",
booktitle = "Mucosal Immunology: Fourth Edition",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Mucosal Vaccines from Plant Biotechnology

AU - Mason, Hugh

AU - Thuenemann, Eva

AU - Kiyono, Hiroshi

AU - Kessans, Sarah

AU - Matoba, Nobuyuki

AU - Leket-Mor, Tsafrir

PY - 2015/4/1

Y1 - 2015/4/1

N2 - The use of plants for production of recombinant proteins has evolved over the past 25. years. The first plant-based vaccines were expressed in stably transgenic plants, with the idea to conveniently deliver "edible vaccines" by ingestion of the antigen-containing plant material. These systems provided a proof of concept that oral delivery of vaccines in crude plant material could stimulate antigen-specific serum and mucosal antibodies. Transgenic grains like rice in particular provide a stable and robust vehicle for antigen delivery. However, some issues exist with stably transgenic plants, including relatively low expression levels and regulatory issues. Thus, many recent studies use transient expression with plant viral vectors to achieve rapid high expression in Nicotiana benthamiana, followed by purification of antigen and intranasal delivery for effective stimulation of mucosal immune responses.

AB - The use of plants for production of recombinant proteins has evolved over the past 25. years. The first plant-based vaccines were expressed in stably transgenic plants, with the idea to conveniently deliver "edible vaccines" by ingestion of the antigen-containing plant material. These systems provided a proof of concept that oral delivery of vaccines in crude plant material could stimulate antigen-specific serum and mucosal antibodies. Transgenic grains like rice in particular provide a stable and robust vehicle for antigen delivery. However, some issues exist with stably transgenic plants, including relatively low expression levels and regulatory issues. Thus, many recent studies use transient expression with plant viral vectors to achieve rapid high expression in Nicotiana benthamiana, followed by purification of antigen and intranasal delivery for effective stimulation of mucosal immune responses.

KW - Animal vaccine

KW - Cholera toxin

KW - Hepatitis B

KW - HIV

KW - MucoRice

KW - Nicotiana benthamiana

KW - Norovirus

KW - Plant vaccine

UR - http://www.scopus.com/inward/record.url?scp=84939550235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939550235&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-415847-4.00065-3

DO - 10.1016/B978-0-12-415847-4.00065-3

M3 - Chapter

SN - 9780124159754

SN - 9780124158474

VL - 2-2

SP - 1271

EP - 1289

BT - Mucosal Immunology: Fourth Edition

PB - Elsevier Inc.

ER -